The Centre expects to receive all 1.65 crore doses of Covid-19 vaccine it had ordered from two manufacturers by Thursday, well in time to start the massive vaccination drive on Saturday, Jan 16. The Centre has ordered 1.1 crore doses of Covishield from the Serum Institute and 55 lakh doses of Covaxin developed by homegrown vaccine maker Bharat Biotech. Meanwhile, Chinese vaccine Coronavac has shown 50% efficacy in Brazil and the US has ramped up its vaccination drive after cases and toll mounted.
Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its Covid-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.
This is the initial lot of supply of vaccine doses and would be continuously replenished in the weeks to come. Therefore, any apprehension being expressed on account of deficient supply is totally baseless and unfounded: Ministry of Health
(ANI)
19:0613 Jan 2021
Full initial procurement amount of 1.65 cr doses of Covishield & Covaxin vaccines allocated to all States/UTs in the proportion of health care workers database. There is no question of discrimination against any State in the allocation of vaccine doses: Ministry of Health